Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Lennartsson

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2010
PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targetsXu Hou, Anil Kumar, Chunsik Lee, et al.
The Journal of Clinical Investigation|January 5, 2005
Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitorsXuri Li, Marc Tjwa, Lieve Moons, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2009
VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesisFan Zhang, Zhongshu Tang, Xu Hou, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2010
PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targetsXu Hou, Anil Kumar, Chunsik Lee, et al.
The Journal of Clinical Investigation|January 5, 2005
Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitorsXuri Li, Marc Tjwa, Lieve Moons, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2009
VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesisFan Zhang, Zhongshu Tang, Xu Hou, et al.
Pageof 8